On November 6, the Release Conference for the 2025 Top 100 Private Enterprises in Sichuan together with the Event of Renowned Sichuan Businesspeople Visiting Luzhou, hosted by the Sichuan Federation of Industry and Commerce (Sichuan General Chamber of Commerce), CPC Luzhou Municipal Committee and Luzhou Municipal People’s Government, was successfully held. The conference aims to sort out and recognize leading private enterprises that have made outstanding contributions to Sichuan’s economic development over the past year. Four authoritative rankings and research reports were officially unveiled on site: the 2025 Top 100 Private Enterprises in Sichuan, Top 100 Private Manufacturing Enterprises in Sichuan, Top 50 Private Service Enterprises in Sichuan, and Top 100 Enterprises with Outstanding R&D Investment.

Relying on stable operating performance, exceptional manufacturing capacity and sustained robust investment in research and development, Good Doctor Group claimed three major honors: “2025 Top 100 Private Enterprises in Sichuan”, “2025 Top 100 Private Manufacturing Enterprises in Sichuan” and “2025 Top 100 Enterprises with Outstanding R&D Investment in Sichuan”, setting a benchmark for the high-quality development of the private economy. Hu Shengping, Assistant to the President of Good Doctor Group, attended the event on behalf of the enterprise to receive the awards.

The “2025 Top 100 Private Enterprises in Sichuan” ranking serves as a vital barometer reflecting the development trend of Sichuan’s private economy. All listed enterprises are industry leaders and the backbone driving high-quality economic development across the province. As one of the most widely watched rankings, it adopts the enterprises’ operating revenue in 2024 as the entry threshold. This year, the threshold reached RMB 3.945 billion, nearly RMB 200 million higher than last year, fully demonstrating the resilience and vitality of Sichuan’s private economy. Overall, six major development characteristics can be observed: continuously rising entry thresholds, prominent position of manufacturing industry, deepening transformation and upgrading, accelerated technological innovation, steady advancement of corporate internationalization, and active fulfillment of social responsibilities.

Good Doctor Group’s presence on the list for eight consecutive years is testimony to its outstanding brand influence, strong market competitiveness and sound momentum of sustained and healthy development. Having cultivated the pharmaceutical and health industry for 39 years, the enterprise maintains strategic resolve and innovative vitality amid a complex and volatile market environment. It keeps expanding business layout, improving product and service quality, and achieves steady growth in key indicators including operating revenue, industrial scale and tax contribution, making important contributions to lifting the overall strength of Sichuan’s private economy.

In the field of smart manufacturing, Good Doctor Group operates modern intelligent production bases, rigorous quality control systems and advanced production technologies, achieving remarkable results in intelligent upgrading. The Group’s newly built Good Doctor Digital Smart Factory was fully put into operation this year. Equipped with 25 extraction production lines and 452 sets of intelligent equipment, it realizes precise control over more than 6,700 key control points via a 120-kilometer pipeline network, with the automation rate of production lines reaching 98%. Good Doctor Group regards product quality as its lifeline, realizing full traceability from raw materials to finished products and consistent high-quality output. Many flagship products including Kangfuxin Liquid, Gutongling Tincture, Kanggan Granules, Qiangqiang Combination, Yumai Kouyan Mixture and Qinggong Longdan enjoy an excellent market reputation.

R&D innovation constitutes the core driver behind Good Doctor Group’s long-term standing on the top 100 list. Guided by the “Four Questions on Traditional Chinese Medicine”: Is traditional Chinese medicine effective? If yes, what creates the therapeutic effect? How does it work? What is the mechanism of action? The Group leverages scientific research platforms such as the National Enterprise Technology Center and Sichuan Provincial Key Laboratory of American Periplaneta and Innovative Drugs to accelerate the development of innovative medicines. The enterprise has achieved fruitful outcomes including invention patents and scientific and technological progress awards. At present, it owns more than 2,000 registered trademarks and over 1,000 valid patents, undertakes more than 70 national-level scientific research projects, and has obtained multiple clinical approvals for first-class original innovative new drugs in the past three years.

Meanwhile, Good Doctor Group takes social responsibility as a key component of its corporate development strategy. It actively engages in public welfare initiatives, striving to become a responsible, approachable and well-loved enterprise and interpreting the mission of private enterprises through concrete actions. For nearly 30 years, the Group has developed the whole industrial chain of Chinese medicinal herbs to help local residents increase income and boost rural development. Its public welfare efforts extend to education, grassroots medical care, culture, elderly care, sports and other social undertakings. For instance, the Group has brought the concept of “Safeguarding Public Health” to sports events. It has supported the Sichuan Super League by sponsoring the “Liangshan Good Doctor Team”, and sponsored the “Good Doctor Cup” National Middle-aged and Elderly Basketball Invitational Tournament together with the 2025 Sichuan Provincial Elderly Basketball Game.

The accolades of three significant honors represent both recognition and motivation. They not only reflect Good Doctor Group’s leading position among private enterprises in Sichuan, but also showcase the vigorous vitality of China’s private economy on the path of innovation-driven development. Going forward, adhering to the original aspiration of “Be a Good Person, Make Quality Medicines”, Good Doctor Group will firmly focus on the core task of high-quality development, further strengthen scientific and technological innovation, strive for breakthroughs in TCM research and development, enable innovative TCM achievements to better serve public health, and inject new momentum into the high-quality development of Sichuan’s private economy.